Search
for
Sort by
Research 691–720 of 1000+
- Incidence and risk factors for alopecia in survivors of critical illness: A multi-centre observational study
- Enhanced Follicular Delivery of Finasteride to Human Scalp Skin Using Heat and Chemical Penetration Enhancers
- Synergistic Potential of Ecklonia cava and Oral Contraceptives inManaging Polycystic Ovary Syndrome: Clinical and BiochemicalEvaluation
- Dermatological drugs, topical agents, and cosmetics
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- Cutaneous manifestations of COVID-19 and vaccines for its prevention: a review of the existing literature
- Polycystic Ovary Syndrome: Current Insights Into Etiology, Symptoms, And Treatment Options
- The skin and obesity
- THE MULTIFACETED APPROACH TO POLYCYSTIC OVARIAN SYNDROME: A REVIEW OF TRADITIONAL AND ALLOPATHIC MEDICINE
- Providing mesotherapy to prevent and treat hair loss in aesthetic practice
- Subject Index
- Auswirkungen einer Hormonersatztherapie mit Testosteron auf Haut, Haare und Anhangsgebilde
- Scaly Papular Lesions
- Hormone therapy for transgender patients
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- Severe cutaneous adverse reactions to drugs
- A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia
- Relationship Between Androgen Levels and Blood Pressure in Young Women With Polycystic Ovary Syndrome
- Cutaneous lupus erythematosus
- Mood and Sexual Function in Polycystic Ovary Syndrome
- Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Female Pattern Hair Loss
- The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran
- Chrousos syndrome: from molecular pathogenesis to therapeutic management
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- Gender-Affirming Hormone Therapy for Transgender Men